JP2003501396A5 - - Google Patents

Download PDF

Info

Publication number
JP2003501396A5
JP2003501396A5 JP2001501241A JP2001501241A JP2003501396A5 JP 2003501396 A5 JP2003501396 A5 JP 2003501396A5 JP 2001501241 A JP2001501241 A JP 2001501241A JP 2001501241 A JP2001501241 A JP 2001501241A JP 2003501396 A5 JP2003501396 A5 JP 2003501396A5
Authority
JP
Japan
Prior art keywords
composition
interleukin
effective amount
therapeutically effective
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001501241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501396A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015737 external-priority patent/WO2000074707A2/en
Publication of JP2003501396A publication Critical patent/JP2003501396A/ja
Publication of JP2003501396A5 publication Critical patent/JP2003501396A5/ja
Pending legal-status Critical Current

Links

JP2001501241A 1999-06-08 2000-06-08 出血性ショックを処置するためのインターロイキン−１１の使用 Pending JP2003501396A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13805499P 1999-06-08 1999-06-08
US60/138,054 1999-06-08
PCT/US2000/015737 WO2000074707A2 (en) 1999-06-08 2000-06-08 Use of interleukin-11 to treat hemorrhagic shock

Publications (2)

Publication Number Publication Date
JP2003501396A JP2003501396A (ja) 2003-01-14
JP2003501396A5 true JP2003501396A5 (enExample) 2007-08-16

Family

ID=22480226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001501241A Pending JP2003501396A (ja) 1999-06-08 2000-06-08 出血性ショックを処置するためのインターロイキン−１１の使用

Country Status (9)

Country Link
EP (1) EP1185292B1 (enExample)
JP (1) JP2003501396A (enExample)
CN (1) CN1355707A (enExample)
AT (1) ATE294590T1 (enExample)
AU (1) AU5328800A (enExample)
CA (1) CA2376358A1 (enExample)
DE (1) DE60019921T2 (enExample)
MX (1) MXPA01012663A (enExample)
WO (1) WO2000074707A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953777B2 (en) 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11

Similar Documents

Publication Publication Date Title
JP2002536387A5 (enExample)
JP2003503454A5 (enExample)
JP2002532112A5 (enExample)
WO2001039777A8 (en) Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
JP2003516325A5 (enExample)
JP2002509074A5 (enExample)
JP2003501516A5 (enExample)
IL130838A (en) Formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
JP2003520017A5 (enExample)
JPH11302527A5 (enExample)
JP2003517041A5 (enExample)
JP2004500325A5 (enExample)
WO2001098270A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
JP2001513504A5 (enExample)
JP2003501396A5 (enExample)
JP2002537232A5 (enExample)
JP2002114686A5 (enExample)
USD454567S1 (en) Game pad
JP2003512511A5 (enExample)
JPH10237071A5 (enExample)
JP2003516751A5 (enExample)
HUP0302210A3 (en) Aqueous single layer rubber-metal binding agents and process for use
CA2304113A1 (en) Hanger for securing a swing chain or the like
JPH1025251A5 (enExample)